FindTrial
Sign In

Yorkshire Collaborative Small Cell Lung Cancer Study

Yorkshire Collaborative Small Cell Lung Cancer Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15654915
Enrollment
Unknown
Registered
2002-08-19
Start date
1994-01-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung (small cell) Cancer Small cell lung

Interventions

Good/moderate-prognosis patients: Patients receive chemotherapy with Ifosfamide, etoposide, mensa and vincristine (EIMV) for three courses. Patients with greater than 50% response are randomised to ei

Sponsors

Northern and Yorkshire Clinical Trials and Research Unit (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Small cell lung cancer confirmed by histological or bronchial brush or aspirate cytology. 2. Aged <75 years 3. Normal renal and hepatic function 4. No evidence of brain metastases 5. No previous specific anti-cancer treatment for current disease 6. No other malignant disease, except basal cell carcinoma and in situ carcinoma of the cervix

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026